Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108LYoshiko Urata, Yoichi Nakanishi, Satoshi Morita et al.|Journal of Clinical Oncology|2016Cited by 160